Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
- Market Cap ₹ 10,416 Cr.
- Current Price ₹ 838
- High / Low ₹ 850 / 274
- Stock P/E 118
- Book Value ₹ 22.0
- Dividend Yield 0.13 %
- ROCE 50.2 %
- ROE 37.9 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 72.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.1%
Cons
- Stock is trading at 38.2 times its book value
- Debtor days have increased from 54.0 to 76.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 106 | 94 | 136 | 146 | 204 | 324 | 469 | |
| 95 | 84 | 119 | 128 | 158 | 231 | 344 | |
| Operating Profit | 11 | 11 | 17 | 18 | 46 | 93 | 125 |
| OPM % | 10% | 11% | 13% | 12% | 23% | 29% | 27% |
| 0 | 1 | 1 | 1 | 2 | 6 | 6 | |
| Interest | 1 | 2 | 1 | 1 | 1 | 0 | 1 |
| Depreciation | 1 | 2 | 2 | 3 | 3 | 5 | 9 |
| Profit before tax | 8 | 8 | 14 | 15 | 45 | 94 | 122 |
| Tax % | 28% | 26% | 27% | 26% | 24% | 26% | 26% |
| 6 | 6 | 10 | 11 | 34 | 69 | 91 | |
| EPS in Rs | 66.67 | 63.67 | 93.55 | 1.24 | 2.71 | 5.57 | 7.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 8% | 17% | 15% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 47% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 73% |
| 3 Years: | 102% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 264% |
| 1 Year: | 198% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 40% |
| Last Year: | 38% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.10 | 10 | 14 | 25 | 25 |
| Reserves | 8 | 14 | 24 | 26 | 112 | 167 | 248 |
| 16 | 12 | 12 | 7 | 1 | 1 | 11 | |
| 12 | 12 | 13 | 18 | 24 | 28 | 45 | |
| Total Liabilities | 36 | 38 | 49 | 62 | 151 | 221 | 328 |
| 13 | 17 | 23 | 28 | 60 | 67 | 153 | |
| CWIP | 0 | 0 | 0 | 5 | 1 | 4 | 13 |
| Investments | 0 | 0 | 0 | 0 | 5 | 4 | 4 |
| 23 | 21 | 26 | 28 | 86 | 146 | 159 | |
| Total Assets | 36 | 38 | 49 | 62 | 151 | 221 | 328 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 1 | 12 | 18 | 17 | 17 | 37 | 69 | |
| -11 | -6 | -8 | -20 | -57 | -18 | -70 | |
| 7 | -5 | -2 | -5 | 48 | -3 | -1 | |
| Net Cash Flow | -2 | 1 | 8 | -7 | 8 | 15 | -2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 17 | 9 | 22 | 40 | 46 | 76 |
| Inventory Days | 204 | 315 | 208 | 136 | 87 | 121 | 135 |
| Days Payable | 125 | 168 | 73 | 109 | 129 | 75 | 111 |
| Cash Conversion Cycle | 94 | 163 | 143 | 49 | -2 | 92 | 100 |
| Working Capital Days | -16 | -15 | -19 | -11 | 29 | 58 | 55 |
| ROCE % | 38% | 50% | 39% | 53% | 58% | 50% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
12 Sep - Jeena Sikho International LLC incorporated 11 Sep 2025; 100% owned; paid-up AED100,000; license valid until 10 Sep 2027.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12 Sep - Jeena Sikho Lifecare partners with Salesforce and Quadrafort for digital transformation; announced Sep 11, 2025 press conference in Chandigarh.
-
Intimation Under Regulation 30 Of SEBI (LODR) - Collaboration With Salesforce For Digital Transformation In Ayurvedic Healthcare
12 Sep - Jeena Sikho Lifecare partners with Salesforce and Quadrafort for Ayurvedic healthcare digital transformation; announced Sept 11, 2025.
-
Disclosure Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') - Commencement Of Operations Of New Hospital At Jammu
12 Sep - Jeena Sikho Lifecare opened 22-room, 40-bed Jammu hospital (13,000 sq ft) starting Sept 11, 2025.
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Approval Of Clinical Trial Of Anti-Diabetes Efficacy Of SDM02 TABLETS, Shuddhi XS Syrup, Petshuddhi Churna And Shuddhi Dr. B P Care Tablets.
8 Sep - Approvals and reports for trials: SDM02 preclinical; Shuddhi XS syrup 60 subjects (12-Jun-25, 92% relief); BP tablets 60 patients (27-Jul-25).
Annual reports
Concalls
-
Aug 2025Transcript PPT
-
Aug 2025TranscriptNotesPPT
-
Jul 2025TranscriptNotesPPTREC
-
May 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024TranscriptNotesPPT REC
-
May 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
Business Segment
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 1,530 operational beds, with another 518 beds in the pipeline.